| |
PANSYS has technical and marketing tie up with INBIOPRO which has a niche science and technology driven KPO organization looking to be at the forefront of the biotechnology revolution.
OUR VISION
At Inbiopro Solutions, we are dedicated to advancing the time taken to bring a biological to the market, with reliable and consistent quality and economy of scale to be affordable to a wider reach of people for healthier, happier lives.
Our mission is to generate and provide technology, tools and training in the field of biological research and manufacturing, meeting the highest global standards. We will achieve this by synergizing latest scientific and engineering knowledge based research, strategic partnerships and process economics to help us in delivering high quality medicinal products to a larger population.
BUSINESS MODEL.
Inbiopro follows a co-development model. We partner with discovery-based companies to take their potential products through the entire development process, towards manufacture, while established players seeking to expand or expedite their pipeline and initiate R&D for novel biologicals.
|
| |
INFRASTRUCTURE
We have 6500 sq.ft. of GLP Standard labs with facilities for
• CELL BIOLOGY • MOLECULAR BIOLOGY
• CELL BASED ASSAY • PROTEIN CHEMISTRY
• MAMMALIAN FERMENTATION (10l, 20l) • DOWNSTREAM PROCESSING
• CELLL CLARIFICATION LAB • MICROBIAL FERMENTATION
• PHAGE SPIKING LAB • CELL CLARIFICATION
Inbiopro is currently developing 12 different therapeutic and vaccine biological, for existing partners and for out-licensing.
E. coli: tPA, PEG-GCSF, GMCSF, PEG-Inerferona-2B, Interferon-g, Interleukin RA, Interleukin 2, human Growth Hormone, Para-Thyroid Hormone, EGF
P. pastoris: recombinant Hepatitis B Antigen
CHO (DHFR-): hCG, FSH, LH, Rituximab, Trantuzumab, Cetuximab, Infliximab
FROM R&D TO MARKET
Complete expertise from early stage development of product to full-scale manufacturing, including process validation. |
